- Home
- DRH vs BCRX Comparison
DRH vs BCRX Comparison
Compare DRH & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRH | BCRX |
|---|---|---|
| Founded | 2004 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2004 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DRH | BCRX |
|---|---|---|
| Price | $12.32 | $8.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 11 |
| Target Price | $10.38 | ★ $20.82 |
| AVG Volume (30 Days) | 2.3M | ★ 3.3M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | 144.44 | ★ 381.40 |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $1,120,491,000.00 | $25,186,000.00 |
| Revenue This Year | $3.44 | N/A |
| Revenue Next Year | $2.42 | $12.55 |
| P/E Ratio | $24.25 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.48 | $6.00 |
| 52 Week High | $13.79 | $11.22 |
Technical Indicators
Market Signals| Indicator | DRH | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.74 | 37.43 |
| Support Level | $11.80 | $8.04 |
| Resistance Level | $12.54 | $10.05 |
| Average True Range (ATR) | 0.29 | 0.30 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 55.98 | 19.45 |
Price Performance
Historical ComparisonAbout DRH Diamondrock Hospitality Company
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The company operates in one reportable segment: The hotel ownership segment, which is comprised of upper upscale and luxury chain scale hotels that offer hotel rooms, food and beverage and other ancillary guest services.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.